Enfusion, Inc.
ENFNNYSETechnology
$10.76
$-0.04(-0.37%)
Market Cap$1.0B
P/E Ratio—
52W High$11.8
52W Low$7.83
Enfusion, Inc. (ENFN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ENFN · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2025Report Date: May 8, 2025EPS Actual
-$0.01
Est. $0.06 · -116.7%
Revenue
—
Est. $0.05B
Fiscal Period
Q2 FY2025
FY ends December
Report Date
May 8, 2025
After Market Close
▼ Miss EPS
ENFN reports quarterly as a NYSE-listed Software - Application company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $6.21B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$6.21B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2025 | Nov 3, 2025 | — | — | — | — | — | — |
| ◌ Q3 FY2025 | Aug 4, 2025 | — | — | — | — | — | — |
| ▼ Q2 FY2025 | May 8, 2025 | $0.06 | -$0.01 | -116.7% | — | $0.05B | — |
| ▼ Q1 FY2025 | Mar 3, 2025 | $0.07 | $0.03 | -57.1% | $0.05B | $0.05B | -2.5% |
| ▼ Q4 FY2024 | Nov 4, 2024 | $0.06 | $0.05 | -16.7% | $0.05B | $0.05B | -1.9% |
| ▼ Q3 FY2024 | Aug 6, 2024 | $0.06 | $0.05 | -16.7% | $0.05B | $0.05B | -9.4% |
| ▲ Q2 FY2024 | May 9, 2024 | $0.04 | $0.06 | +65.5% | $0.05B | $0.05B | +0.9% |
| ▼ Q1 FY2024 | Mar 12, 2024 | $0.06 | $0.04 | -33.3% | $0.05B | $0.05B | +2.7% |
Q4 FY2025
Nov 3, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Aug 4, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 8, 2025Miss
EPS Actual
-$0.01
EPS Est.
$0.06
EPS Surpr.
-116.7%
Revenue
—
Q1 FY2025
Mar 3, 2025Miss
EPS Actual
$0.03
EPS Est.
$0.07
EPS Surpr.
-57.1%
Revenue
$0.05B
Q4 FY2024
Nov 4, 2024Miss
EPS Actual
$0.05
EPS Est.
$0.06
EPS Surpr.
-16.7%
Revenue
$0.05B
Q3 FY2024
Aug 6, 2024Miss
EPS Actual
$0.05
EPS Est.
$0.06
EPS Surpr.
-16.7%
Revenue
$0.05B
Q2 FY2024
May 9, 2024Beat
EPS Actual
$0.06
EPS Est.
$0.04
EPS Surpr.
+65.5%
Revenue
$0.05B
Q1 FY2024
Mar 12, 2024Miss
EPS Actual
$0.04
EPS Est.
$0.06
EPS Surpr.
-33.3%
Revenue
$0.05B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.12 | $0.12 | $0.12 | 1 |
| Q3 FY2027 | $0.10 | $0.10 | $0.10 | 1 |
| Q2 FY2027 | $0.09 | $0.09 | $0.09 | 1 |
| Q1 FY2027 | $0.09 | $0.09 | $0.09 | 1 |
| Q4 FY2026 | $0.10 | $0.10 | $0.10 | 1 |
| Q3 FY2026 | $0.10 | $0.10 | $0.10 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2025 | May 8, 2025 | -116.7% | $10.76 | — | — |
| ▼ Q1 FY2025 | Mar 3, 2025 | -57.1% | $11.48 | $11.37 | -0.96% |
| ▼ Q4 FY2024 | Nov 4, 2024 | -16.7% | $9.05 | $8.72 | -3.65% |
| ▼ Q3 FY2024 | Aug 6, 2024 | -16.7% | $8.65 | $7.97 | -7.86% |
| ▲ Q2 FY2024 | May 9, 2024 | +65.5% | $9.77 | $9.26 | -5.22% |
| ▼ Q1 FY2024 | Mar 12, 2024 | -33.3% | $8.52 | $9.36 | +9.86% |
| ▼ Q4 FY2023 | Nov 7, 2023 | -20.0% | $8.28 | $8.60 | +3.86% |
| ▼ Q3 FY2023 | Aug 8, 2023 | -20.0% | $10.00 | $8.73 | -12.70% |
Q2 FY2025—
Report Date
May 8, 2025
EPS Beat/Miss
-116.7%
Price Before
$10.76
Price After
—
Q1 FY2025-0.96%
Report Date
Mar 3, 2025
EPS Beat/Miss
-57.1%
Price Before
$11.48
Price After
$11.37
Q4 FY2024-3.65%
Report Date
Nov 4, 2024
EPS Beat/Miss
-16.7%
Price Before
$9.05
Price After
$8.72
Q3 FY2024-7.86%
Report Date
Aug 6, 2024
EPS Beat/Miss
-16.7%
Price Before
$8.65
Price After
$7.97
Q2 FY2024-5.22%
Report Date
May 9, 2024
EPS Beat/Miss
+65.5%
Price Before
$9.77
Price After
$9.26
Q1 FY2024+9.86%
Report Date
Mar 12, 2024
EPS Beat/Miss
-33.3%
Price Before
$8.52
Price After
$9.36
Q4 FY2023+3.86%
Report Date
Nov 7, 2023
EPS Beat/Miss
-20.0%
Price Before
$8.28
Price After
$8.60
Q3 FY2023-12.70%
Report Date
Aug 8, 2023
EPS Beat/Miss
-20.0%
Price Before
$10.00
Price After
$8.73
Avg Beat Reaction-5.22%
Avg Miss Reaction-1.91%
Beat Rate1 / 8 quarters
Largest Move-12.70% (Q3 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ENFN ends December
Enfusion, Inc. (ENFN) most recently reported earnings on May 8, 2025 for Q2 FY2025, posting EPS of $-0.01 — missing the analyst consensus of $0.06 by -116.7%. The next ENFN earnings date is expected around September 1, 2026.
Each quarter, investors track ENFN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ENFN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ENFN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ENFN earnings · 5 questionsEnfusion, Inc.'s next earnings report is expected around September 1, 2026. ENFN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ENFN historically reports after market close (AMC).
ENFN earnings datewhen is ENFN earningsENFN next earnings datewhen does ENFN report earningsENFN earnings calendar
▸ Source: FMP · Enfusion, Inc. SEC filings · US GAAP · Enfusion, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026